Expert Shares Insight on Immunotherapy, Emerging Strategies in Prostate Cancer – OncLive
OncLive |
Expert Shares Insight on Immunotherapy, Emerging Strategies in Prostate Cancer
OncLive 2018 may be the year that checkpoint inhibition breaks through in the treatment landscape of prostate cancer, according to David R. Wise, MD, PhD. Currently, the only immunotherapy approved specifically for the treatment of patients with prostate … |
